These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32631560)

  • 1. Synthesis and evaluation of
    Lin Q; Zhang Y; Fu Z; Hu B; Si Z; Zhao Y; Shi H; Cheng D
    Bioorg Med Chem; 2020 Aug; 28(15):115577. PubMed ID: 32631560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography.
    Iommelli F; De Rosa V; Gargiulo S; Panico M; Monti M; Greco A; Gramanzini M; Ortosecco G; Fonti R; Brunetti A; Del Vecchio S
    Clin Cancer Res; 2014 Sep; 20(18):4806-15. PubMed ID: 25052479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-[
    Buck JR; Saleh S; Claus T; Lovly C; Hight MR; Nickels ML; Noor Tantawy M; Charles Manning H
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127257. PubMed ID: 32631505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy.
    Makino A; Miyazaki A; Tomoike A; Kimura H; Arimitsu K; Hirata M; Ohmomo Y; Nishii R; Okazawa H; Kiyono Y; Ono M; Saji H
    Bioorg Med Chem; 2018 May; 26(8):1609-1613. PubMed ID: 29478801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preliminary evaluation of
    Lu X; Wang C; Li X; Gu P; Jia L; Zhang L
    Bioorg Med Chem; 2019 Feb; 27(3):545-551. PubMed ID: 30611635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study.
    Wang W; Wang H; Lu P; Yu Z; Xu C; Zhuang W; Song Z
    J Transl Med; 2019 Feb; 17(1):52. PubMed ID: 30791921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
    Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
    Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
    Cullinane C; Dorow DS; Jackson S; Solomon B; Bogatyreva E; Binns D; Young R; Arango ME; Christensen JG; McArthur GA; Hicks RJ
    J Nucl Med; 2011 Aug; 52(8):1261-7. PubMed ID: 21764800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by
    Iommelli F; De Rosa V; Terlizzi C; Monti M; Panico M; Fonti R; Del Vecchio S
    Clin Cancer Res; 2018 Jul; 24(13):3126-3136. PubMed ID: 29618618
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
    Han Z; Xiao Y; Wang K; Yan J; Xiao Z; Fang F; Jin Z; Liu Y; Sun X; Shen B
    J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
    Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
    J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
    Sugano T; Seike M; Noro R; Soeno C; Chiba M; Zou F; Nakamichi S; Nishijima N; Matsumoto M; Miyanaga A; Kubota K; Gemma A
    Mol Cancer Ther; 2015 Nov; 14(11):2433-40. PubMed ID: 26351321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary application of micro-SPECT/CT imaging by
    Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
    Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of deuterium-labeled crizotinib, a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).
    Ao W; Li Y; Zhang Y
    J Labelled Comp Radiopharm; 2018 Dec; 61(14):1036-1042. PubMed ID: 30118545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoke enhances oncogene addiction to c-MET and desensitizes EGFR-expressing non-small cell lung cancer to EGFR TKIs.
    Tu CY; Cheng FJ; Chen CM; Wang SL; Hsiao YC; Chen CH; Hsia TC; He YH; Wang BW; Hsieh IS; Yeh YL; Tang CH; Chen YJ; Huang WC
    Mol Oncol; 2018 May; 12(5):705-723. PubMed ID: 29570930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crizotinib, a small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases.
    Rodig SJ; Shapiro GI
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1477-90. PubMed ID: 21154129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancer.
    Kogita A; Togashi Y; Hayashi H; Banno E; Terashima M; De Velasco MA; Sakai K; Fujita Y; Tomida S; Takeyama Y; Okuno K; Nakagawa K; Nishio K
    Int J Oncol; 2015 Mar; 46(3):1025-30. PubMed ID: 25502629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step synthesis of [
    Lien VT; Klaveness J; Olberg DE
    J Labelled Comp Radiopharm; 2018 Jan; 61(1):11-17. PubMed ID: 28921623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.